141 results
Page 5 of 8
8-K
7gfu1bqy qdr80ewvl
19 Jun 20
Patent License Agreement
5:26pm
8-K
kjwbv fyrhkjuw4ujn
15 Jun 20
Entry into a Material Definitive Agreement
4:13pm
8-K
xpyr cbjd
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
i73ujj ej
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
7zhqq2
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
ifnz9g ihq
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
8-K
EX-99.1
8adehz4 grryem0mpo3
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
DEF 14A
l0kcglzmb1xe8yh9
6 Apr 20
Definitive proxy
4:52pm
8-K
zhp7nd1ar9
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
8-K
EX-99.1
v46isan31fkfb4b 8n
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
10-K
EX-4.4
xfr tb9iij1mxv5h
26 Mar 20
Annual report
4:08pm
10-K
lut 2fh2p81yq7v
26 Mar 20
Annual report
4:08pm
10-K
EX-10.12
ivoqk0
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
d6m124114xx4wl0q1c
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
10-Q
ekani3 fv5dfpwacqjw
19 Nov 19
Quarterly report
4:06pm
S-8
EX-4.8
3sdgyxd6b 5lq
15 Oct 19
Registration of securities for employees
4:47pm
S-8
EX-4.11
s8rw80m
15 Oct 19
Registration of securities for employees
4:47pm
424B4
txz6qmj
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
EX-10.2
zi2b5pu 5c
30 Sep 19
IPO registration (amended)
6:12am